BOSTON, MA – On October 9, Wilmington residents will be running in the 16th annual B.A.A. Half Marathon presented by Dana-Farber Cancer Institute and the Jimmy Fund, as a member of the official Dana-Farber team.
These Wilmington runners include:
- Kelly Kollias
- Jocelyne O’Brien
Five hundred Dana-Farber team members will raise awareness and at least $750 each to support adult and pediatric patient care and cancer research at Dana-Farber. Dana-Farber and the Jimmy Fund have sponsored the B.A.A. Half Marathon for 14 years. During this time, runners on the Dana-Farber team have raised more than $5 million to fuel lifesaving work at the Institute. To support a runner in the B.A.A. Half Marathon, go to http://www.RunDanaFarber.org.
“We are overjoyed to see both longtime runners and first-time participants join the Dana-Farber team for next month’s race,” says Jan Ross, assistant vice president, running programs, Dana-Farber Cancer Institute, division of development & the Jimmy Fund. “Our team members are as committed to finding cures for cancer by fundraising for the Jimmy Fund as they are to their personal fitness goals, and the entire Dana-Farber community is grateful for the progress that their dedication and hard work makes possible.”
The 13.1-mile rolling course is an out-and-back loop that runs along the Emerald Necklace park system. It will begin and end in White Stadium in Boston’s Franklin Park. The event attracts a field of 9,000 runners, including world-class athletes.
The race is one of three annual fundraising events in the longstanding partnership between the Boston Athletic Association and Dana-Farber. The Boston Marathon® Jimmy Fund Walk presented by Hyundai is the only walk sanctioned to take place along the historic Boston Marathon route, and the Dana-Farber Marathon Challenge (DFMC) is a team of Dana-Farber runners who participate in the Boston Marathon each April.
To learn more about running for Dana-Farber or to support a runner, please visit http://www.rundanafarber.org. If you have registered to run the B.A.A. Half Marathon and would like to fundraise for Dana-Farber, please call the Dana-Farber Running Programs office at (617) 632-1970 or (800) 551-7036.
About the Jimmy Fund
The Jimmy Fund (www.JimmyFund.org) solely supports Boston’s Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world. It is an official charity of the Boston Red Sox, as well as the official charity of the Massachusetts Chiefs of Police Association, the Pan-Mass Challenge, and the Variety Children’s Charity of New England. Since 1948, the generosity of millions of people has helped the Jimmy Fund save countless lives and reduce the burden of cancer for patients and families worldwide. Follow the Jimmy Fund on Facebook: http://www.facebook.com/thejimmyfund and on Twitter: @TheJimmyFund.
About Dana-Farber Cancer Institute
From achieving the first remissions in cancer with chemotherapy in 1948, to developing the very latest new therapies, Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. It is the only center ranked in the top 4 of U.S. News and World Report’s Best Hospitals for both adult and pediatric cancer care.
Dana-Farber sits at the center of a wide range of collaborative efforts to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber/Brigham and Women’s Cancer Center provides the latest in cancer care for adults; Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for children. The Dana-Farber/Harvard Cancer Center unites the cancer research efforts of five Harvard academic medical centers and two graduate schools, while Dana-Farber Community Cancer Care provides high quality cancer treatment in communities outside Boston’s Longwood Medical Area.
Dana-Farber is dedicated to a unique 50/50 balance between cancer research and care, and much of the Institute’s work is dedicated to translating the results of its discovery into new treatments for patients locally, and around the world.
(NOTE: The above press release is from the Dana-Farber Cancer Institute.)
Like Wilmington Apple on Facebook. Follow Wilmington Apple on Twitter. Subscribe to Wilmington Apple’s daily email newsletter HERE. Got a comment, question, photo, press release, or news tip? Email email@example.com.